)
)
Information on this page is intended for UK healthcare professionals only and may contain promotional material
This page is only intended for UK healthcare professionals. Adverse event reporting can be found near the bottom of the page.
Tillotts Products may be discussed in the content of these modules where prescribing information will be available.
About IDEAL
Tillotts IDEAL is an educational initiative developed by Tillotts Pharma UK and Ireland to help both new and experienced healthcare professionals enhance their understanding of Clostridioides difficile infection (CDI), to support our healthcare colleagues improve patient care.
Tillotts IDEAL Education is an educational initiative organised and funded by Tillotts Pharma UK and Ireland. Tillotts Products may be discussed in the content of these modules where prescribing information and adverse event reporting information will be available.
Introduction
Clostridioides difficile infection (CDI) is the most common infectious cause of nosocomial diarrhoea in the UK. This diarrhoea can be life-threatening and is associated with significant morbidity, mortality and financial burden.1,2
Working alongside key opinion leaders in the infection prevention field, Tillotts identified a need for educational resources to further develop healthcare professionals knowledge of CDI.
IDEAL has been developed using our experience from the past nine years of upskilling healthcare professionals working in Inflammatory Bowel Disease (IBD) through the Tillotts LOGIC Education program. Tillotts is committed to working with our healthcare colleagues to help improve outcomes for CDI patients as part of our ongoing commitment to the NHS.
Why learn with Tillotts IDEAL Education?
The Tillotts e-Learning platform is free and offers a range of training appropriate for all healthcare professionals regardless of familiarity with CDI.
Tillotts has over 9 years experience in providing quality education through the Tillotts LOGIC initiative, training healthcare professionals working in Inflammatory Bowel Disease.
On demand learning to complete at your own pace.
The modules feature interactive questions to reinforce learning.
Certificates provided on completion for your CPD records.
To begin learning through IDEAL please visit the Tillotts eLearning platform
Register here)
)
)
Report a side effect
Adverse events should be reported. Reporting forms and information can be found at:
Adverse events should also be reported to Tillotts Pharma UK Ltd on:
T. 01522 813500
1. Tresman R & Goldenberg S. J Antimicrob Chemother 2018;73:2851-2855.
2. Finn E, et al. Burden of Clostridioides difficile infection (CDI) – a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis 21, 456 (2021).
PU-03395 | July 2026
